Hidden in the lungs of some breast cancer survivors are tumour cells that can remain dormant for decades — until they one day ...

New evidence suggests that SARS-CoV-2 infection can lead to the rapid development of achalasia, a rare esophageal motility disorder. The etiology of achalasia is unclear. Studies have suggested an ...

Among the participants who tested positive for SARS-CoV-2 infection, 475 developed T1D during the post-acute period, with an incidence rate of 90.5 (95% CI, 82.7-99.0) per 100,000 person-years ...

Early in the beginning of the COVID-19 pandemic, scientists predicted the SARS-CoV-2 virus would mutate slowly. They were wrong. Hundreds of thousands of viral mutations and multiple seasonal ...

Nirmatrelvir is a potent, selective SARS-CoV-2 main protease inhibitor. 18,19 The Evaluation of Protease Inhibition for Covid-19 in High-Risk Patients (EPIC-HR) trial involving patients at high ...

With climate change bringing more frequent and severe heat waves to much of the U.S. and the world, people will likely be spending even more time indoors in summertime—and so will SARS-CoV-2.

To determine whether multiple SARS-CoV-2 infections impact the risk for long COVID, Clouston and colleagues retrospectively studied data from 2,511 essential workers in New York, most of whom were ...

New genetic analyses reveal that the bat virus ancestors of SARS-CoV-1 and SARS-CoV-2 likely circulated in Western China or Northern Laos just years before human outbreaks. Their rapid appearance ...